Pathogenic germline variants identified in patients with lung cancer
A total of 14.9 percent of patients with lung cancer have pathogenic germline variants (PGV), most of which are potentially clinically actionable, according to a study presented Aug. 16 as part of the American Society for ...
Aug 22, 2022
0
49



